企业版公测上线啦!点击立即查看
登录 注册
当前位置: 首页 > FDA历年批准NMEs及Biologics 反馈纠错 帮助中心
药智数据企业版注册数据库:增设了"联合申报"、"临床试验默认许可日期"等搜索条件,让搜索页面纬度更加全面,还有热点搜索和高级条件组合检索等检索功能 等你来体验!
-
药品名称 批准类型 活性成分 适应症 上市发布公告 临床试验快照 批准日期 申请机构
Nexletol - bempedoic acid To treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C 2020-02-21 -
Vyepti - eptinezumab-jjmr For the preventive treatment of migraine in adults 2020-02-21 -
Pizensy NME lactitol To treat chronic idiopathic constipation (CIC) in adults 2020-02-12 BRAINTREE LABS
Tazverik NME tazemetostat To treat epithelioid sarcoma Press Release Drug Trials Snapshot 2020-01-23 EPIZYME INC
Tepezza Biologics teprotumumab-trbw To treat Thyroid eye disease Press Release Drug Trials Snapshot 2020-01-21 HORIZON THERAPEUTICS IRELAND
Ayvakit NME avapritinib To treat adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) Drug Trials Snapshot 2020-01-09 BLUEPRINT MEDICINES
Xpovio NME selinexor To treat adult patients with relapsed or refractory multiple myeloma (RRMM) Press Release 2019/07/03 KARYOPHARM THERAPEUTICS INC
Polivy Biologics polatuzumab vedotin-piiq To treat adult patients with relapsed or refractory diffuse large B-cell lymphoma Press Release 2019/06/10 GENENTECH
Piqray NME alpelisib To treat breast cancer Press Release Drug Trials Snapshot 2019/05/24 NOVARTIS PHARMS CORP
Vyndaqel NME tafamidis meglumine To treat heart disease (cardiomyopathy) caused by transthyretin mediated amyloidosis (ATTR-CM) in adults Press Release  Drug Trials Snapshot 2019/05/03 FOLDRX PHARMS
Skyrizi Biologics risankizumab-rzaa To treat moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy Drug Trials Snapshot 2019/04/23 ABBVIE INC
Balversa NME erdafitinib To treat adult patients with locally advanced or metastatic bladder cancer Press Release Drug Trials Snapshot 2019/04/12 JANSSEN BIOTECH
Evenity Biologics romosozumab-aqqg To treat osteoporosis in postmenopausal women at high risk of fracture Press Release Drug Trials Snapshot 2019/04/09  AMGEN INC
Mayzent NME siponimod To treat adults with relapsing forms of multiple sclerosis Press Release Drug Trials Snapshot 2019/03/26  NOVARTIS PHARMS CORP
Sunosi NME solriamfetol To treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea Drug Trials Snapshot 2019/03/20  JAZZ
Zulresso NME brexanolone To treat postpartum depression (PPD) in adult women Press Release Drug Trials Snapshot 2019/03/19 SAGE THERAP
Egaten NME triclabendazole To treat fascioliasis, a parasitic infestation caused by two species of flatworms or trematodes that mainly the affect the liver, sometimes referred to as “liver flukes” Drug Trials Snapshot 2019/02/13 NOVARTIS PHARMS CORP
Cablivi Biologics caplacizumab-yhdp To treat adult patients with acquired thrombotic thrombocytopenic purpura (aTTP) Press Release Drug Trials Snapshot 2019/02/06 ABLYNX NV
JEUVEAU Biologics PRABOTULINUMTOXINA-XVFS For the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients Drug Trials Snapshot 2019/02/01 EVOLUS INC
Ubrelvy NME ubrogepant to treat acute treatment of migraine with or without aura in adults Press Release Drug Trials Snapshot 2019-12-23 ALLERGAN